• Citer

Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials Group.

par Verweij, Jaap;Wanders, Jantien;Nielsen, A L;Pavlidis, N;Calabresi, F;ten Bokkel Huinink, Wim;Bruntsch, U;Piccart-Gebhart, Martine ;Franklin, H;Kaye, S B
Référence Annals of oncology, 5, 4, page (375-376)
Publication Publié, 1994-04

Article révisé par les pairs

• Détails
• Contenu

Titre:	Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials Group.
Auteur:	Verweij, Jaap; Wanders, Jantien; Nielsen, A L; Pavlidis, N; Calabresi, F; ten Bokkel Huinink, Wim; Bruntsch, U; Piccart-Gebhart, Martine; Franklin, H; Kaye, S B
Informations sur la publication:	Annals of oncology, 5, 4, page (375-376)
Statut de publication:	Publié, 1994-04
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Breast
	Colorectum
	Elsamitrucin
	Nonsmall cell lung
	Ovary
	Phase II
MeSH keywords:	Adolescent
	Adult
	Aged
	Aminoglycosides
	Anti-Bacterial Agents -- adverse effects
	Anti-Bacterial Agents -- therapeutic use
	Antibiotics, Antineoplastic -- adverse effects
	Antibiotics, Antineoplastic -- therapeutic use
	Breast Neoplasms -- drug therapy
	Carcinoma, Non-Small-Cell Lung -- drug therapy
	Colorectal Neoplasms -- drug therapy
	Drug Administration Schedule
	Female
	Follow-Up Studies
	Humans
	Lung Neoplasms -- drug therapy
	Male
	Middle Aged
	Neoplasms -- drug therapy
	Ovarian Neoplasms -- drug therapy
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:scp/0028346970
	info:pmid/8075039